| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Sale | -$2.26M | -10.6K | -7.21% | $213.01 | 137K | 10 Nov 2023 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a written agreement governing the terms of restricted stock units granted to the reporting person, which includes a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) to satisfy tax obligations arising out of the vesting of such stock units (the "Sell-to-Cover Trading Arrangement"). The written agreement, adopted December 14, 2022, provides that, if the filer is in possession of material, nonpublic information as of the date of grant of such stock units, then the Sell-to-Cover Trading Arrangement becomes a binding contract as of the first date thereafter on which the filer is not in possession of material, nonpublic information. |
| F2 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |